Skip to content

Benefit of surgical clearance of mesopancreatic trinagle tissue situated between major vessel superior mesentric artery coeliac artery and superior mesentric vein during pancreaticoduodectomy for perimapullary cancer patients

Utility of mesopancreas triangle clearance with level 2 mesopancreas dissection in pancreaticoduodenectomy for resectable periampullary carcinomas

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/11/046981
Enrollment
112
Registered
2022-11-02
Start date
Unknown
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Mesopancreas Triangle Tissue: Part 1 PPPDor Classical Whipple s procedure with level 2Meso-pancreas Dissection: En bloc LNs dissection in the mesopancreas by the central vessel ligation

Sponsors

Tata Memorial Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: -Patients scheduled to undergo elective PPPD for resectable periampullary carcinoma. -Patients with Eastern Cooperative Oncology Group performance status of 0â??2 -Patients providing written informed consent based on sufficient understanding of the study.

Exclusion criteria

Exclusion criteria: -Patients requiring multivisceral resection. -Patients requiring vascular resection or reconstruction. -Patients scheduled to undergo laparoscopic or laparoscopy assisted PD or robotic PD. -Patients receiving neoadjuvant therapy in view of borderlineresectable or locally advanced status

Design outcomes

Primary

MeasureTime frame
To perform dedicated histopathological analysis of a)Main specimen for assessment of theR(margin) status b)Assess the Mesopancreas triangle tissue fortumor cell positivity c)Assess LN yield with LV2 dissection and triangle clearance Timepoint: 2 weeks

Secondary

MeasureTime frame
-To determine the perioperative morbidity and mortality -Recurrence rates -Local recurrences -Distant recurrences -Disease free survival -Overall survival Timepoint: 24 month

Countries

India

Contacts

Public ContactDr Vikram Chaudhari

Tata Memorial Hospital

drvikramchaudhari@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026